Related Experiment Video
Updated: Jul 27, 2026

07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
[Thymomas with a myasthenic syndrome]
Khirurgiia
|July 29, 1998
Summary
Surgery for thymic tumors (TT) in generalized myasthenia (Gm) patients shows improved outcomes with advanced diagnostics like CT and MRI. Long-term results vary by thymoma type, with medullar and mixed types yielding better prognoses post-thymectomy.
Area of Science:
- Thoracic Surgery
- Neurosurgery
- Oncology
Background:
- Generalized myasthenia (Gm) is often associated with thymic abnormalities.
- Thymic tumors (TT) are the most common neoplastic masses in the anterior mediastinum.
- A significant percentage of Gm patients present with organ-specific thymic tumors.
Purpose of the Study:
- To analyze the surgical outcomes for patients with generalized myasthenia and thymic tumors.
- To evaluate the effectiveness of diagnostic methods for thymic tumors.
- To assess the long-term results of thymectomy based on thymoma histology.
Main Methods:
- Retrospective analysis of 2560 Gm patients operated between 1960-1996.
- Diagnostic imaging including CT and MRI for thymic tumor detection.
- Thymectomy performed on 247 patients, with detailed histogenetic classification of thymomas.
Main Results:
- Thymic tumors (organ-specific) were found in 252 of 312 patients with thymic masses.
- CT and MRI demonstrated high sensitivity and specificity for diagnosing thymic tumors.
- Postoperative lethality decreased to zero in recent years (1990-1996).
- Early complications included wound infection (2.5%), pneumonia (1.3%), and myasthenic crisis (1.6%).
- Long-term outcomes were poorer for cortical thymomas compared to medullar and mixed types.
Conclusions:
- Thymectomy is a crucial treatment for Gm patients with thymic tumors.
- Diagnostic accuracy for thymic tumors has improved with advanced imaging techniques.
- Histogenetic classification of thymomas is essential for predicting long-term outcomes after thymectomy.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

